title: Maternal methadone dose during pregnancy and infant clinical outcome: response to O'Grady et al.
abstract: We agree with O'Grady et al. (2013) that the relationships between maternal methadone dose during pregnancy and neonatal outcomes deserve serious attention. However, we would also argue that a broader range of infant health and neurobehavioral outcomes need to be considered, not only in the short but also the longer term.
authors.affiliation: Department of Psychological Medicine, Faculty of Medical and Health Science, University of Auckland, Auckland 1142, New Zealand. Electronic address: t.wouldes@auckland.ac.nz.
authors.forename: Trecia A
authors.initials: TA
authors.lastname: Wouldes
authors.forename: Lianne J
authors.initials: LJ
authors.lastname: Woodward
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D005260:Female; D006801:Humans; D018811:Maternal Exposure / Q000009:adverse effects*; D008691:Methadone / Q000008:administration & dosage* / Q000009:adverse effects*; D009357:Neonatal Abstinence Syndrome / Q000209:etiology*; D011247:Pregnancy; D011256:Pregnancy Outcome
chemical_list: D008691:Methadone
keywords: Maternal methadone maintenance treatment; Neonatal outcomes